The Effect of Prinomastat (AG3340), a Synthetic Inhibitor of Matrix Metalloproteinases, on Posttraumatic Proliferative Vitreoretinopathy

By  

Ophthalmic Research, Vol. 33, Iss. 1, 2000-12 ,pp. : 20-23

Karger

Access to resources Recommend Favorite

The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy

By Ozerdem Ugur   Mach-Hofacre Beata   Cheng Lingyun   Chaidhawangul Sunan   Keefe Kelly   McDermott Charles D.   Bergeron-Lynn Germaine   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 20, Iss. 6, 2000-06 ,pp. : 447-453

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Prinomastat® (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization

By Garcia Claudio R.   Bartsch Dirk-Uwe   Rivero Maria E.   Hagedorn Martin   McDermott Charles D.   Bergeron-Lynn Germaine   Cheng Lingyun   Appelt Krzysztof   Freeman William R.  

Current Eye Research, Vol. 24, Iss. 1, 2002-01 ,pp. : 33-38

Informa Healthcare

Access to resources Recommend Favorite

Differential Expression of Tissue Inhibitor of Matrix Metalloproteinases 3 in Uveal Melanoma

By  

Ophthalmic Research, Vol. 37, Iss. 1, 2005-04 ,pp. : 23-28

Karger

Access to resources Recommend Favorite

Use of the Chick Embryo Model in Uveal Melanoma

By  

Ocular Oncology and Pathology, Vol. 1, Iss. 3, 2015-04 ,pp. : 133-140

Karger

Access to resources Recommend Favorite